Inhalational Anesthesia and Precipitation of Dementia: is There a Link?

Sponsor

University Health Network, Toronto (Other)

Overall Status

Active, not recruiting

CT.gov ID

NCT01903421

Collaborator

(none)

500

Enrollment

Locations

Arms

Anticipated Duration (Months)

166.7

Patients Per Site

1.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Many elderly patients undergoing surgical procedures already have impaired cognitive (memory/concentration) status. Patients with pre-existing cognitive impairment, or dementia, may benefit from modified anesthesia techniques. It is estimated that one in eight people age 65 and older has Alzheimers disease. More so, nearly half of people that are 85 years or older have Alzheimers disease. Currently, both spinal (regional) and inhalational (general) anesthesia, are used in patients undergoing common urological, orthopedic, and general surgical procedures. Inhalational anesthesia has been associated with higher risk of memory impairment in experimental (animal) and human studies. However, currently, there are simply no large or good enough studies to be sure that inhalational anesthesia is responsible for causing dementia and Alzheimers disease.The proposed study investigates if elderly patients (65 years and older) undergoing spinal anesthesia (patient is awake or slightly sedated) are less likely to develop dementia and Alzheimers disease for up to 2 years after surgery, when compared to inhalational anesthesia (patient is kept asleep with gas anesthetic). The investigators will also test all patients for the presence of apolipoprotein (ApoE-Îμ4 type of gene that is present in 15-20% of patients), and beta-amyloid tau protein (present in cerebrospinal fluid) that are known risk factors for Alzheimers disease. The particular strength of this study is that it takes into account whether the frequency and/or severity of dementia and Alzheimers disease is different in patients with and without these markers. The investigators believe that this study will make a major contribution to better understanding of development of Alzheimers disease.

Condition or Disease	Intervention/Treatment	Phase
Alzheimer's Disease Dementia	Drug: Spinal anesthesia group: bupivacaine 10-15mg Drug: General anesthesia group: induction propofol 1.5-2mg/kg and fentanyl 1-3g/kg, maintained with isoflurane or sevoflurane Genetic: Blood test Other: Lumbar spinal tap Behavioral: Montreal Cognitive Assessment (MOCA) and MMSE	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

500 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Intervention Model Description:

The proposed study will be a prospective, multicenter, cluster randomization clinical trial comparing two different anesthetic techniques in elderly patients (> 65 years of age) undergoing urology/orthopedic/general surgery. The study will follow a cluster design; patients undergoing orthopedic or vascular surgery will have spinal anesthesia, where standard practice. Patients undergoing urology or general surgery will receive general anesthesia, also where it is standard practice. Patients with severe dementia will be excluded.The proposed study will be a prospective, multicenter, cluster randomization clinical trial comparing two different anesthetic techniques in elderly patients (> 65 years of age) undergoing urology/orthopedic/general surgery. The study will follow a cluster design; patients undergoing orthopedic or vascular surgery will have spinal anesthesia, where standard practice. Patients undergoing urology or general surgery will receive general anesthesia, also where it is standard practice. Patients with severe dementia will be excluded.

Masking:

None (Open Label)

Primary Purpose:

Prevention

Official Title:

Inhalational Anesthesia and Precipitation of Dementia: is There a Link? A Prospective, Multicenter, Randomized, Controlled Clinical Trial Comparing Two Different Anesthetic Techniques in Elderly Patients

Actual Study Start Date :

Mar 1, 2014

Actual Primary Completion Date :

Nov 1, 2019

Anticipated Study Completion Date :

Dec 1, 2021

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Spinal anesthesia group Spinal anesthesia group will receive bupivacaine 10-15mg anesthesia according to the standard practice. Supplemental sedation with intravenous anesthetics (midazolam/propofol) will be optional.	Drug: Spinal anesthesia group: bupivacaine 10-15mg Genetic: Blood test DNA will be tested for the presence of ε4 allele of the apolipoprotein E gene Other: Lumbar spinal tap 1ml of cerebrospinal fluid (CSF) removed and stored for further analysis of amyloid tau protein after completion of the study Behavioral: Montreal Cognitive Assessment (MOCA) and MMSE
Active Comparator: General anesthesia group Induction of anesthesia will be achieved with propofol 1.5-2mg/kg and fentanyl 1-3g/kg. Anesthesia will be maintained with inhalational anesthesia (isoflurane or sevoflurane) at the discretion of anesthesiologist in charge of the case. A mixture of Air/O2 will be used to maintain adequate oxygenation. Nitrous oxide will not be used.	Drug: General anesthesia group: induction propofol 1.5-2mg/kg and fentanyl 1-3g/kg, maintained with isoflurane or sevoflurane Genetic: Blood test DNA will be tested for the presence of ε4 allele of the apolipoprotein E gene Other: Lumbar spinal tap 1ml of cerebrospinal fluid (CSF) removed and stored for further analysis of amyloid tau protein after completion of the study Behavioral: Montreal Cognitive Assessment (MOCA) and MMSE

Arm

Intervention/Treatment

Active Comparator: Spinal anesthesia group

Spinal anesthesia group will receive bupivacaine 10-15mg anesthesia according to the standard practice. Supplemental sedation with intravenous anesthetics (midazolam/propofol) will be optional.

Drug: Spinal anesthesia group: bupivacaine 10-15mg

Genetic: Blood test

DNA will be tested for the presence of ε4 allele of the apolipoprotein E gene

Other: Lumbar spinal tap

1ml of cerebrospinal fluid (CSF) removed and stored for further analysis of amyloid tau protein after completion of the study

Behavioral: Montreal Cognitive Assessment (MOCA) and MMSE

Active Comparator: General anesthesia group

Induction of anesthesia will be achieved with propofol 1.5-2mg/kg and fentanyl 1-3g/kg. Anesthesia will be maintained with inhalational anesthesia (isoflurane or sevoflurane) at the discretion of anesthesiologist in charge of the case. A mixture of Air/O2 will be used to maintain adequate oxygenation. Nitrous oxide will not be used.

Drug: General anesthesia group: induction propofol 1.5-2mg/kg and fentanyl 1-3g/kg, maintained with isoflurane or sevoflurane

Genetic: Blood test

DNA will be tested for the presence of ε4 allele of the apolipoprotein E gene

Other: Lumbar spinal tap

1ml of cerebrospinal fluid (CSF) removed and stored for further analysis of amyloid tau protein after completion of the study

Behavioral: Montreal Cognitive Assessment (MOCA) and MMSE

Outcome Measures

Primary Outcome Measures

Assessing the incidence of early dementia [Change from baseline, hospital discharge (3 day average), 3 months, 1 year, and 2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:

65 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

65 yrs of age
Male or female
Scheduled to undergo urologic procedures (e.g., transurethral resection of prostate, transurethral resection of bladder tumor), orthopedic (e.g., total knee replacement, total hip replacement) general (e.g., femoral hernia repair, lower abdominal surgery) or vascular surgery procedures (e.g. lower limb reperfusion amputations) and qualifies to be randomized to receive either local (spinal) or general anesthetic

Exclusion Criteria:

Diagnosis of severe dementia
Diagnosis of any other significant neurological disease such as Parkinson's, multi-infarct dementia, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, or history of significant head trauma followed by persistent neurologic defaults or known structural brain or spinal abnormalities.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Toronto General Hospital, University Health Network	Toronto	Ontario	Canada	M5G 2C4
2	William Osler Health Centre	Toronto	Ontario	Canada	M9V 1R8
3	Pauls Stradins Clinical University Hospital	Riga		Latvia	LV 1002